Sam Lidman: Daily

The Canadian HVAC giant's acquisition of a 63-year-old family distributor isn't just about market share; it's a blueprint for continental dominance.

As America readies for its 250th, one Virginia town isn't just celebrating history—it's weaponizing it as a savvy economic strategy for long-term resilience.

As regulators and consumers demand healthier food, a new strategy emerges. It’s not about removing ingredients, but redesigning taste from the ground up.

SeaStar Medical prepares to present its life-saving organ failure technology to investors. We explore its newly approved product, pivotal adult trial, and vast market potential.

At ACE26, American Water isn't just attending a conference; it's leveraging its 140-year legacy to confront the critical challenges of America's water future.

Zebra Technologies' new machine vision ecosystem isn't just about cameras; it's a strategic play to build resilient, augmented, and hyper-efficient factories.

Intellicheck’s entry into the Russell 2000 validates its growth. But what does this mean for investors and the broader fight against digital identity fraud?

Beyond the finish line, VCARB and Salesforce are building an 'Agentic Enterprise,' using AI not just for speed, but for permanent fan connection and operational strength.

As Prime Day looms, a new survey reveals a deep split. Younger shoppers embrace AI and deals, while older consumers remain skeptical. What does this mean for retail?

As Kyverna eyes a first-in-class approval for its CAR T-cell therapy, it brings in a legal and compliance veteran with a prosecutor's edge to clear the path.

Merck's positive Phase 3 results for tulisokibart signal a new era for UC care, targeting both fibrosis and inflammation in a potential first-in-class win.

A new platform from Newtn Digital aims to automate the archaic world of medical equipment ordering, a sector bleeding billions from paper-based inefficiencies.

As Abigail Buckwalter takes the helm at Ocean Spray, the iconic cooperative bets on her global CPG expertise. Can she drive growth while honoring its farmer-owned roots?

Beyond a catchy TikTok challenge, Comfee's strategy in Malaysia reveals a masterclass in building brand resilience by merging smart tech with social currency.

Genialis's new BioBridge platform uses AI to de-risk the $137B flow of oncology drugs from China to the West, a critical test of resilience.

A top Beijing forum reveals China's strategic shift. As trade with the West cools, it's finding a 'blue ocean' in the Global South with a new model of engagement.

After the flames, a new battle emerges. California fire survivors are fighting for a seat at the table as regulators take on State Farm over alleged systemic delays.

Record Financial Group and the EBRD are pioneering a new investment model in Mongolia, revealing how local currency bonds build resilience and unlock returns.

With $75.6B in billings, Omnicom is now the undisputed giant. But can it turn sheer size into real value for clients and avoid a culture clash?

A scientific shift from replacement to regeneration is fueling a market set to surpass $100B. But can new players navigate the regulatory and commercial hurdles?